APA (7th ed.) Citation

E. P. PANCHENKO. (2017). HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? «REMEDIUM GROUP» Ltd..

Chicago Style (17th ed.) Citation

E. P. PANCHENKO. HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? «REMEDIUM GROUP» Ltd., 2017.

MLA (9th ed.) Citation

E. P. PANCHENKO. HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? «REMEDIUM GROUP» Ltd., 2017.